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Medicine, Sapporo 060-8638, JapanAbstract—Around a quarter of neurons in laminae I–II of the
dorsal horn are inhibitory interneurons. These play an
important role in modulating somatosensory information,
including that perceived as pain or itch. Previous studies
in rat identiﬁed four largely non-overlapping neurochemical
populations among these cells, deﬁned by expression of
galanin, neuropeptide Y (NPY), neuronal nitric oxide syn-
thase (nNOS) or parvalbumin. The galanin cells were subse-
quently shown to coexpress dynorphin. Several recent
studies have used genetically modiﬁed mice to investigate
the function of diﬀerent interneuron populations, and it is
therefore important to determine whether the same pattern
applies in mouse, and to estimate the relative sizes of these
populations. We show that the neurochemical organization
of inhibitory interneurons in mouse superﬁcial dorsal horn
is similar to that in the rat, although a larger proportion of
these neurons (33%) express NPY. Between them, these four
populations account for 75% of inhibitory cells in laminae
I–II. Since 25% of inhibitory interneurons in this region
belong to a novel calretinin-expressing type, our results
suggest that virtually all inhibitory interneurons in superﬁ-
cial dorsal horn can be assigned to one of these ﬁve neuro-
chemical populations. Although our main focus was
inhibitory neurons, we also identiﬁed a population of excita-
tory dynorphin-expressing cells in laminae I–II that are lar-
gely restricted to the medial part of the mid-lumbar dorsal
horn, corresponding to glabrous skin territory. These ﬁnd-
ings are important for interpretation of studies using
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INTRODUCTION
The spinal dorsal horn receives sensory input from a wide
variety of primary aﬀerents, including nociceptors,
pruritoceptors, thermoreceptors and low-threshold
mechanoreceptors, and these terminate in a highly
organized pattern within speciﬁc laminae (Todd, 2010,
2017; Abraira and Ginty, 2013; Braz et al., 2014). The
incoming sensory information is processed through com-
plex synaptic circuits before being transmitted via projec-
tion neurons to the brain (for conscious perception), as
well as to neurons involved in spinal reﬂex pathways.
The main components involved in these modulatory cir-
cuits are local interneurons, which are extremely numer-
ous, and are thought to constitute around 99% of the
neurons within the dorsal horn (Abraira and Ginty,
2013). Dorsal horn interneurons can be divided into two
broad functional classes: inhibitory neurons, which use
GABA and/or glycine as their principal fast transmitter,
and excitatory (glutamatergic) neurons (Todd et al.,
2003; Yasaka et al., 2010; Zeilhofer et al., 2012). Quanti-
tative studies in the mouse have shown that the inhibitory
interneurons account for around one quarter of the neu-
rons in lamina I–II and 40% of those in lamina III. These
cells are known to have an important role in suppressing
pain and itch, and loss of this function is thought to con-
tribute to pathological pain states (Yaksh, 1989; Coull
et al., 2003; Sandkuhler, 2009; Kardon et al., 2014;
Foster et al., 2015; Petitjean et al., 2015).
The inhibitory interneurons can be divided into speciﬁc
classes, based on the expression of certain
neuropeptides and proteins (Todd, 2010, 2017; Braz
et al., 2014), and there is increasing evidence that these
neurochemical classes correspond to functional popula-
tions. For example, they diﬀer in laminar location, which
is likely to reﬂect speciﬁc patterns of primary aﬀerent input
to each class, and in their responses to noxious stimuli
(Polgar et al., 2013b). In 2011, we identiﬁed four largely/licenses/by/4.0/).
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interneurons in laminae I–III of the rat spinal cord, deﬁned
by expression of galanin, neuropeptide Y (NPY), neuronal
nitric oxide synthase (nNOS) and parvalbumin (Tiong
et al., 2011). We subsequently reported that most of the
galanin-containing cells also express the opioid peptide
dynorphin, although dynorphin was also found in some
excitatory interneurons (Sardella et al., 2011a). Between
them, these four populations (galanin/dynorphin, NPY,
nNOS and parvalbumin) were thought to account for just
over half of the inhibitory interneurons in laminae I–II
(Todd, 2017).
Since then, several studies have made use of these
neurochemical features to manipulate the activity of
neuronal populations in genetically modiﬁed mouse lines
and test the eﬀects on pain and itch behavior (Duan
et al., 2014; Bourane et al., 2015; Foster et al., 2015;
Petitjean et al., 2015). These studies have provided
important insights into the functions of inhibitory interneu-
ron populations. However, interpretation of ﬁndings from
studies of this type is complicated, ﬁrstly because proteins
of interest may be transiently expressed by certain neu-
rons in the dorsal horn (Duan et al., 2014; Bourane
et al., 2015; Gutierrez-Mecinas et al., 2017), meaning that
behavioral changes cannot necessarily be attributed to
the intended neuronal populations. In addition, single neu-
rochemical/genetic markers are often expressed by more
than one functional population. For example, nNOS, par-
valbumin and dynorphin are also found in signiﬁcant num-
bers of excitatory interneurons. Finally, although similar
neurochemical populations to those that we deﬁned in
the rat can be identiﬁed in the mouse dorsal horn, less
is known about the sizes of these populations, or the
extent to which they overlap. Indeed, there appear to be
some species diﬀerences, because unlike the situation
in the rat, nNOS and galanin show signiﬁcant overlap in
the mouse (Iwagaki et al., 2013; Kardon et al., 2014).
The main aim of this study was to deﬁne and quantify
neurochemical populations among the inhibitory
interneurons in the mouse superﬁcial dorsal horn, and to
determine what proportion of the inhibitory neurons they
account for. This information will be of importance for
interpreting studies in which speciﬁc interneuron
populations are targeted in genetically modiﬁed mice.EXPERIMENTAL PROCEDURES
Animals
All experiments were approved by the Ethical Review
Process Applications Panel of the University of
Glasgow, and were performed in accordance with the
European Community directive 86/609/EC and the UK
Animals (Scientiﬁc Procedures) Act 1986.
Nine adult C57Bl/6 mice of either sex (20–28 g) were
deeply anesthetized with pentobarbitone (30 mg i.p.) and
perfused through the left cardiac ventricle with ﬁxative
consisting of 4% freshly depolymerized formaldehyde in
phosphate buﬀer. Lumbar spinal cord segments were
removed and stored at 4 C for 2 h in the same ﬁxative.
Tissue from these mice was processed forimmunocytochemistry (see below) to reveal interneurons
belonging to diﬀerent neurochemical populations.
As an additional way of identifying neurons that
express dynorphin, we also analyzed tissue from mice
in which Cre recombinase had been knocked into the
prodynorphin gene (PdynCre) (Krashes et al., 2014).
PdynCre mice were crossed with the Ai9 reporter line
(Jackson Laboratory; Stock number 007909), in which
Cre-mediated excision of a STOP cassette drives expres-
sion of the red ﬂuorescent protein tdTomato (tdTom). The
resulting mice (PdynCre;Ai9) should have tdTom in all neu-
rons that have expressed dynorphin at any stage during
development. Four male PdynCre;Ai9 mice (20–25 g) were
anesthetized and perfused with ﬁxative, and spinal cord
tissue was removed and processed as described above.
To distinguish neurons that continue to express
dynorphin past the early postnatal period, we performed
intraspinal injections of adeno-associated (AAV) virus
(serotype 1) carrying a conditional (Cre-dependent)
enhanced green ﬂuorescent protein (eGFP) expression
cassette (AAV.ﬂex.eGFP; Penn Vector Core,
Philadelphia, PA USA) (Gutierrez-Mecinas et al., 2017).
The virus encodes the inverted sequence for eGFP
between pairs of heterotypic LoxP sites with antiparallel
orientation (Atasoy et al., 2008). The rationale for this
approach is that in infected dorsal horn neurons that
express Cre at the time of injection, there will be perma-
nent reversal of the coding sequence, resulting in expres-
sion of eGFP. Three PdynCre;Ai9 mice (either sex, 15–
17 g, aged P30–44) were anesthetized with isoﬂurane
and received two injections of AAV.ﬂex.eGFP (each
1.7  109 GC in 300 nl) into the dorsal horn on the right
side, as described previously (Gutierrez-Mecinas et al.,
2017). The injections were made on either side of the
T13 vertebra, at 300 lm from the midline and at a depth
of 300 lm below the pial surface. The wound was closed
and the animals allowed to recover with appropriate post-
operative analgesia. After a survival period of 13 or
14 days, they were re-anesthetized and ﬁxed by perfu-
sion, and tissue was processed as described above.
General features of immunostaining and confocal
microscopy
Lumbar spinal cord segments were cut into 60-lm-thick
transverse sections with a vibrating blade microtome.
These were immersed for 30 min in 50% ethanol to
enhance antibody penetration and reacted for multiple-
labeling immunoﬂuorescence staining as described
previously (Gutierrez-Mecinas et al., 2014, 2016;
Cameron et al., 2015; Ganley et al., 2015). Details of
the antibodies used in this study, including the sources
and concentrations, are provided in Table 1. Unless other-
wise stated, the sections were incubated for 3 days at
4 C in primary antibodies diluted in PBS that contained
0.3 M NaCl, 0.3% Triton X-100 and 5% normal donkey
serum, and then overnight in species-speciﬁc secondary
antibodies (Jackson Immunoresearch, West Grove, PA,
USA) that were raised in donkey and conjugated to Alexa
488, Alexa 647, Rhodamine Red, Paciﬁc Blue or biotin. All
secondary antibodies were diluted 1:500 (in the same
diluent), apart from those conjugated to Rhodamine Red
Table 1. Antibodies used in this study
Antibody Species Catalog no Dilution Source
NPY Rabbit T-4070 1:1000 Peninsula
Galanin Rabbit T-4334 1:1000 Peninsula
PPD Guinea pig 1:5000* T Furuta
PPD Rabbit 1:10,000* T Furuta
nNOS Goat 1:1000 M Watanabe
Parvalbumin Guinea pig 1:2500 M Watanabe
sst2A Guinea pig SS870 1:2000 Gramsch Laboratories
Pax2 Rabbit 716000 1:1000 Life Technologies
NeuN Mouse MAB377 1:500 Merck
PKCc Rabbit sc211 1:1000 Santa Cruz Biotechnology
* For tyramide signal ampliﬁcation.
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respectively. Biotinylated secondary antibodies were
detected either with Paciﬁc Blue conjugated to avidin
(1:1000; Life Technologies, Paisley, UK) or with a tyra-
mide signal ampliﬁcation (TSA) method (TSA kits tetram-
ethylrhodamine NEL702001 or Cy5 NEL705A001,
PerkinElmer Life Sciences, Boston, MA, USA). The TSA
reaction was used to detect antibody against prepro-
dynorphin (PPD), as this method can be used to reveal
the cell bodies of dorsal horn neurons that express dynor-
phin (Sardella et al., 2011a, Kardon et al., 2014). Sections
were mounted in anti-fade medium and stored at 20 C.
Immunostained sections were scanned with a Zeiss
LSM710 confocal microscope equipped with Argon
multi-line, 405-nm diode, 561-nm solid state and 633-nm
HeNe lasers. Confocal image stacks, generally
consisting of at least 30 optical sections (with a z-
separation of 1 lm), were obtained from the entire
mediolateral extent of the dorsal horn through a 40 oil-
immersion lens (numerical aperture 1.3) with the
confocal aperture set to 1 Airy unit or less. The resulting
z-stacks were analyzed with Neurolucida for Confocal
software (MBF Bioscience, Williston, VT, USA). Most of
the analysis was carried out on the superﬁcial dorsal
horn (laminae I and II). The border between laminae II
and III was identiﬁed either based on the relatively low
packing density of neurons in the inner half of lamina II
(Rexed, 1952; Molander et al., 1984; Todd et al., 1998)
or by staining for protein kinase Cc (PKCc), which labels
a dense plexus of dendrites that extends ventrally as far
as the lamina II/III border (Hughes et al., 2003). In some
cases, lamina III was included in the analysis and its ven-
tral border was identiﬁed by the reduction in neuronal
packing density seen in lamina IV. Quantitative analyses
were generally performed using a modiﬁcation (Polga´r
et al., 2004) of the disector method (Sterio, 1984) on sec-
tions that had been immunostained for NeuN, and in
some cases counterstained with the nuclear stain 40,6-dia
midino-2-phenylindole (DAPI). The reference and look-up
sections were set between 10 and 20 lm apart, and all
neurons for which the bottom surface of the soma (or
nucleus, in sections stained with DAPI) lay between these
optical sections were included in the analysis. In cases
where we estimated the density of cells per unit length
of spinal cord, a correction factor was applied to compen-
sate for tissue shrinkage in the z-axis (Polga´r et al., 2004;Polgar et al., 2013a). This factor was the measured z-
depth of the section as seen on the confocal microscope,
divided by the original section thickness (60-lm).NPY-expressing interneurons
Sections from the L4 segment of four mice were reacted
with antibodies against NPY, PPD, sst2A and NeuN.
These were used to estimate the proportion of neurons
in laminae I–III that are NPY-immunoreactive, to
determine the extent of co-localization between NPY
and dynorphin, and to test whether cells that contained
both neuropeptides expressed sst2A. Three or four
sections from each mouse were scanned and analyzed
with the disector method. The NeuN channel was
initially used to mark the location of neurons in the
disector sample that were located in laminae I–II and in
lamina III. The other channels were then viewed and the
expression of PPD, NPY and/or sst2A in each selected
neuron was recorded.
It has been reported that all NPY-immunoreactive
neurons in laminae I–III of the rat dorsal horn are also
GABA-immunoreactive, and are therefore inhibitory
interneurons (Rowan et al., 1993). To test whether this
is also the case in the mouse we immunostained sections
from the L4 segments of three mice to reveal NPY and the
transcription factor Pax2. Pax2 is restricted to inhibitory
interneurons, and has been shown to be expressed by
all of the inhibitory cells in laminae I–III (Kardon et al.,
2014; Foster et al., 2015; Larsson, 2017). Because both
antibodies are raised in the rabbit, we used a sequential
staining method. Sections were initially incubated in the
Pax2 and NeuN antibodies, which were detected with
secondary antibodies conjugated to Alexa 488 and Alexa
647, respectively. They were then reacted with rabbit anti-
NPY which was revealed with Rhodamine Red. Finally,
they were counterstained with DAPI. Although the
Pax2+ nuclei were labeled with both Alexa 488 and Rho-
damine Red, this staining was restricted to the cell
nucleus, and was clearly distinct from cytoplasmic stain-
ing for NPY (which was labeled only with Rhodamine
Red). Two sections from each mouse were scanned
and examined with the Neurolucida for Confocal. We
searched for neurons in laminae I–III that showed NPY
immunoreactivity in their perikaryal cytoplasm and looked
for the presence of Pax2 staining in the nucleus.
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with antibodies against NPY, nNOS and parvalbumin, in
order to assess any overlap between these three
neurochemical markers. Two sections from each of
three mice were scanned and analyzed. We selected
parvalbumin-positive cells in laminae I–III that had a
bottom surface within a speciﬁed 20- to 30-lm depth of
the section, and then determined whether they were
nNOS- or NPY-immunoreactive. We then selected NPY-
positive cells in the same way and tested whether they
were nNOS-immunoreactive.
Dynorphin-expressing interneurons
Dynorphin is expressed by both inhibitory and excitatory
interneurons in the superﬁcial dorsal horn (Sardella
et al., 2011a, Duan et al., 2014). To assess the relative
frequency and the distribution of these two cell types,
we scanned sections from the L4 segments of wild-type
mice that had been reacted with antibodies against
PPD, Pax2, sst2A and NeuN (three sections per mouse
from each segment, n= 4 mice). As described above,
neurons included in the disector sample were identiﬁed
and the expression of PPD, Pax2 and sst2A was recorded
for each cell. During the course of this analysis, we noted
that there was a distinctive mediolateral distribution of the
excitatory PPD cells within the dorsal horn, raising the
possibility that this was related to sensory inputs from
glabrous and hairy skin. We therefore examined the distri-
bution of PPD cells in the L2 segment, which only
receives input from hairy skin (Takahashi et al., 2003).
A single section reacted to reveal PPD, Pax2 and NeuN
was scanned from each of four mice, and the distribution
of Pax2+ and Pax2 PPD neurons was recorded.
Many of the dynorphin-positive inhibitory interneurons
also contain galanin (Brohl et al., 2008; Sardella et al.,
2011a), and virtually all galanin-containing cells express
the somatostatin receptor sst2A (Iwagaki et al., 2013;
Polgar et al., 2013b). In order to assess the extent of colo-
calization of PPD and galanin, we therefore examined
expression of PPD, galanin, sst2A and NeuN in three sec-
tions from the L4 segments of each of four mice. Neurons
that were immunoreactive for galanin and sst2A were ini-
tially selected, and these were then assessed for the
presence of PPD. PPD+/sst2A
+ neurons that lacked gala-
nin were then identiﬁed.
To explore the developmental relationship between
dynorphin and nNOS we examined tissue from the L4
segment of PdynCre;Ai9 mice. Initially, we quantiﬁed the
proportion of neurons that were tdTom+ in sections
reacted to reveal NeuN and PKCc, and then
counterstained with DAPI (n= 4 mice), using the
disector method. We then determined the extent to
which inhibitory and excitatory nNOS cells were labeled
with tdTom, by examining sections reacted with
antibodies against nNOS and Pax2 (n= 2 mice), and
testing all nNOS+ cells in the section for the presence
of Pax2 and tdTom.
In order to characterize neurons that continue to
express dynorphin, we examined tissue from close to
the injection site in the L4 segment of PdynCre;Ai9 mice
that had received intraspinal injections of AAV.ﬂex.eGFP. Sections from three mice were reacted with
antibodies against PPD and nNOS. TdTom+ cells that
had their bottom surface within a 20- to 30-lm depth of
the section were initially identiﬁed, and these were then
tested for the presence of GFP, PPD and nNOS.
Characterization of antibodies
We have shown that immunostaining with the NPY and
galanin antibodies is abolished by preincubation with
corresponding peptide (Rowan et al., 1993; Simmons
et al., 1995). The two antibodies against PPD were raised
against a peptide corresponding to amino acids 229–248
at the C terminus of rat PPD, and have been shown to
label PPD, but not dynorphin or enkephalin. In addition,
immunostaining is blocked by pre-absorption of the anti-
bodies with the immunizing peptide (Lee et al., 1997).
The nNOS antibody was raised against the C-terminal
15 amino acids of mouse nNOS. Immunostaining with this
antibody co-localizes perfectly with that of a well-
characterized nNOS antibody raised in rabbit (AJT,
MGM unpublished observations). The parvalbumin anti-
body is directed against the mouse protein and recog-
nizes a band of 13 kDa on Western blots of mouse
brain homogenates (Nakamura et al., 2004). The sst2A
antibody was raised against the C terminal 15 amino
acids of mouse sst2A receptor coupled to keyhole limpet
hemocyanin, and immunostaining is blocked by incuba-
tion with the peptide antigen (manufacturer’s speciﬁca-
tion). The Pax2 antibody was raised against amino
acids 188–385 of the mouse protein, and recognizes
bands of the appropriate size on Western blots of mouse
embryonic kidney (Dressler and Douglass, 1992). The
NeuN antibody was raised against cell nuclei extracted
from mouse brain and found to react with a protein speci-
ﬁc for neurons (Mullen et al., 1992), which has subse-
quently been identiﬁed as the splicing factor Fox-3 (Kim
et al., 2009). The PKCc antibody was raised against a
peptide corresponding to the C terminus of mouse PKCc,
and we have shown that it stains identical structures to
those labeled with a well-characterized guinea-pig anti-
body against PKCc (Sardella et al., 2011b).
Statistical analysis
The Chi-squared test was used to determine whether
nNOS-immunoreactive cells were over-represented
among cells that were labeled with tdTomato but not
eGFP in the PdynCre;Ai9 mice that had been injected
with AAV.ﬂex.eGFP. Fisher’s exact probability test was
used to determine whether the diﬀerence in the
proportion of PPD neurons that were inhibitory or
excitatory diﬀered signiﬁcantly between the L2 and L4
segments. A p value of <0.05 was taken as signiﬁcant.
RESULTS
Quantiﬁcation of NPY cells
The distribution of NPY-immunoreactivity in the mouse
dorsal horn was the same as that reported previously in
both mouse and rat (Hunt et al., 1981; Gibson et al.,
1984; Rowan et al., 1993; Solway et al., 2011; Iwagaki
Fig. 1. NPY expression in the mouse dorsal horn. (A) A low magniﬁcation view of NPY-
immunoreactivity in the L4 segment of the mouse dorsal horn. The dashed line
represents the border between laminae II and III. There is a plexus of NPY staining, which
mostly corresponds to axons, and this is densest in laminae I–II, with scattered axons in
deeper laminae. In this image, it is diﬃcult to see NPY-immunoreactive cell bodies, as
these are obscured by the axonal plexus. Inset: In a single optical section, NPY-
immunoreactive neurons can readily be detected by the presence of immunostaining in
the perikaryal cytoplasm. Two of these cells are visible, and are indicated with arrows.
(B–D) A single confocal optical section through a section that had been reacted to reveal
Pax2 (green), NPY (red) and NeuN (blue). Because the NPY and Pax2 antibodies are
both raised in rabbit, the reaction was performed sequentially (for further details see text).
Three NPY-expressing cells (arrows) can be recognized by the presence of NPY
immunoreactivity in their perikaryal cytoplasm, and in all 3 cases the nucleus is Pax2-
positive, indicating that these are inhibitory interneurons. The main image in A is a
projection of 30 optical sections at 1-lmz-spacing. Scale bars = 100 lm (main image in A)
and 20 lm (B–D and inset in A). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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dense plexus in laminae I–II, and were more sparsely dis-
tributed in deeper laminae. Occasional dense bundles of
axons were also seen in laminae III–IV, and it has been
shown previously that these are associated with the den-
dritic trees of projection neurons belonging to the antero-
lateral tract (Polga´r et al., 1999; Cameron et al., 2015). At
high magniﬁcation, NPY-immunoreactive cell bodies
could readily be identiﬁed by the immunostaining in their
perikaryal cytoplasm (Fig. 1a inset). Quantitative analysis
revealed that NPY-immunoreactive cells accounted for
8.4% (range 6.9–9.8%, n= 4 mice) and 9.5% (7.1–
12.3%) of all neurons in laminae I–II and in lamina III,
respectively. In the sections reacted for both NPY and
Pax2, NPY-immunoreactivity could easily be detected inthe perikaryal cytoplasm of certain neurons,
even though Pax2 ﬂuorescence in cell nuclei
was also seen in the Rhodamine Red channel
due to the sequential staining method
(Fig. 1b–d). We identiﬁed a total of 265
(range 66–103, n= 3 mice) NPY-
immunoreactive cells in laminae I–II and
146 (41–55) such cells in lamina III, and
found that all of these cells showed Pax2-
immunoreactivity in their nuclei. Although we
did not analyze the deeper dorsal horn lami-
nae (IV–VI), we did observe a few NPY cells
that lacked Pax2 in this region.
We have previously reported that
inhibitory (GABA-immunoreactive) cells
account for 25.8% of all neurons in laminae
I–II and 37.6% of those in lamina III (Polgar
et al., 2013a). We therefore estimate that
NPY-immunoreactive cells account for 33%
of the inhibitory interneurons in laminae I–II
and for 25% of those in lamina III.
Colocalization of NPY with dynorphin,
sst2A, parvalbumin and nNOS
In the sections reacted to reveal NPY, PPD,
sst2A and NeuN, we restricted the analysis
of colocalization to laminae I–II, because
inhibitory PPD cells are infrequent in deeper
laminae. We identiﬁed 192 NPY+ cells
(range 32–71, n= 4 mice) and 277 PPD+
cells (52–87) in laminae I–II. We found that
13.1% (5.3–19.7%) of the NPY-
immunoreactive cells also contained PPD
immunoreactivity, and this corresponded to
9.3% (3.6–16.9%) of the PPD+ cells.
Among the neurons with immunoreactivity
for both peptides 20 out of 27 (74%) cells
were sst2A
+ (Fig. 2).
In sections reacted to reveal NPY, nNOS
and parvalbumin (Fig. 3), we identiﬁed a total
of 121 parvalbumin-immunoreactive neurons
in laminae I–II (range 20–59, n= 3 mice),
and 366 (89–139) such cells in lamina III,
reﬂecting the much higher density of
parvalbumin cells in deeper laminae,
compared to the superﬁcial dorsal horn,seen in the mouse (Hughes et al., 2012). Quantitative
analysis revealed that in laminae I–II there were 4.8 par-
valbumin cells per 10 lm length of the L4 segment. This
length of the mouse L4 segment would be expected to
contain 124.8 neurons, of which 25.8% (i.e. 32.2 neurons)
are inhibitory (Polgar et al., 2013a). We have shown that
75% of parvalbumin neurons in laminae I–II are inhibitory
in the rat (Laing et al., 1994) and a similar proportion has
been seen for parvalbumin neurons in laminae I–III of the
mouse (Abraira et al., 2017). Based on this, we estimate
that parvalbumin cells account for 11% of the inhibitory
interneurons in laminae I–II. None of the parvalbumin
cells in laminae I–II and only 1 out of 366 parvalbumin
cells in lamina III were nNOS-immunoreactive. There
was very limited overlap between parvalbumin and NPY:
Fig. 2. Co-expression of neuropeptide Y (NPY) and preprodynorphin (PPD) in a lamina II neuron. A scan through laminae I and II from a section
that had been reacted with antibodies against neuropeptide Y (NPY, green), preprodynorphin (PPD, red), NeuN (blue) and sst2A (gray). (A) Two
NPY-immunoreactive cells are indicated (arrowhead and double arrow) and in each case, the immunoreactivity is present in the perikaryal
cytoplasm. (B) The cell marked with the double arrow, and another cell (indicated with an arrow) are PPD-immunoreactive. (C) Staining with the
NeuN antibody shows that these three cells are all neurons. (D) sst2A is expressed by the 2 PPD-positive neurons (arrow, double-arrow), but not by
the cell that was NPY-positive and PPD-negative (arrowhead). (E) A merged image, shows the relationship between NPY-, PPD- and NeuN-
immunoreactivities. The images represent projections of 3 optical sections at 1-lm z-spacing. Scale bar = 20 lm. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. Lack of overlap between cells that express NPY, parvalbumin (PV) and nNOS in the
inner part of lamina II. (A) A single optical section from tissue that had been scanned to reveal
PV (green), NPY (red) and nNOS (blue). (B) The same optical section, but with
immunostaining for NeuN shown in gray. Four cells have been highlighted: two of these (*)
are immunoreactive for PV, one (arrow) for NPY and one (arrowhead) for nNOS. Staining for
NPY and nNOS is in the perikaryal cytoplasm, and the nucleus of these cells can be seen due
to immunostaining for NeuN in (B). Scale bar = 20 lm. (For interpretation of the references
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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I–II, and 7 out of 366 (1.9%) of those in lamina III were
NPY-immunoreactive. However, since this overlap is
likely to be restricted to inhibitory parvalbumin cells (which
are thought to correspond to 75% of all parvalbumin neu-
rons), the extent of overlap is probably somewhat higher
for these cells: 4.3% in laminae I–II and 2.5% in lamina
III. To determine the extent of overlap of NPY and nNOS,
we identiﬁed 247 NPY-positive cells (71–101) in laminae
I–II and 140 (43–49) in lamina III. We found that 4.4%
of those in laminae I–II and 6.4% of those in lamina III
were also nNOS-immunoreactive.Expression of preprodynorphin and its relation to
galanin
In sections reacted to reveal PPD, the distribution of
immunostaining was similar to that seen in the rat
(Sardella et al., 2011a), with a dense plexus in the super-
ﬁcial dorsal horn and scattered proﬁles in the deeper lam-inae (Fig. 4). PPD-immunoreactive
neurons were present throughout the dor-
sal horn, but they were most numerous in
laminae I–II. In the sections analyzed from
the L4 segment, PPD was detected in 203
lamina I–II neurons (range 41–67 n= 4
mice), and these corresponded to 11.3%
(9.9–12.6%) of all neurons in laminae I–II.
The majority of these cells (67%, range
54–76%) were Pax2-immunoreactive,
and could therefore be identiﬁed as inhibi-
tory interneurons. The PPD+/Pax2+ cells
accounted for 30.8% (25.7–35.2%) of the
Pax2 cells in lamina I–II. The great major-
ity (91%, range 84.4–100%) of the inhibi-
tory PPD cells were sst2A, and these
accounted for 54% (48.2–58.2%) of the
sst2A-immunoreactive cells. Interestingly,
we found that although the inhibitory
PPD cells were uniformly distributed
across the mediolateral extent of the dor-sal horn, the excitatory (Pax2-negative) PPD cells
showed a highly uneven distribution, being largely
restricted to the medial one third (Fig. 5a, c–h). Within this
medial region we also observed numerous Pax2-negative
PPD cells in lamina III. The medial part of the L4 segment
receives inputs from primary aﬀerents that innervate glab-
rous skin, raising the possibility that dynorphin-expressing
excitatory interneurons are predominantly associated with
this type of input. To test this, we also examined sections
from the L2 segment, which is only innervated by aﬀer-
ents from hairy skin (Takahashi et al., 2003). We identi-
ﬁed PPD-positive cells in a 20-lm disector from 1
section in each of four mice and determined whether
these cells were Pax2-immunoreactive. As predicted,
we found a quite diﬀerent pattern, with a far higher propor-
tion of PPD-immunoreactive cells being Pax2-positive
(90%, 66/73 PPD cells in laminae I–II, data pooled from
four mice). Unlike the situation in L4, there was no cluster-
ing of PPD+/Pax2 cells in the medial part of laminae I–II,
Fig. 4. Preprodynorphin (PPD) immunoreactivity in the mouse dorsal
horn. Confocal image of a transverse section through the L4 segment,
reacted with antibody against PPD. A dense band of immunostaining is
present in lamina I and the dorsal part of lamina II, with variable
extension into the ventral part of lamina II. This region contains several
immunoreactive cell bodies, and these are seen more clearly in the inset
(corresponding to the box in the main image), in which four immunore-
active cells are visible. Lamina III contains a few scattered immunore-
active axons and cell bodies, while immunoreactive axons are more
numerous in laminae IV–V. Dashed lines represent the dorsal and
ventral borders of lamina III. The main image is a projection of 30 optical
sections and the inset is a projection of three sections. In each case the
z-spacing is 1 lm. Scale bar = 100 lm.
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part of lamina III (Fig. 5b). The diﬀerence in the proportion
of inhibitory and excitatory PPD cells between the L4 and
L2 segments was highly signiﬁcant (Fisher’s exact proba-
bility test, p< 0.0001).
In sections reacted with antibodies against galanin,
PPD, sst2A and NeuN we restricted the analysis to
neurons that were sst2A-immunoreactive, because
virtually all galanin neurons (Iwagaki et al., 2013) and
the great majority of inhibitory PPD neurons (see above)
express this receptor. We identiﬁed 256 (range 59–72,
n= 4 mice) galanin+/sst2A
+ neurons and 288 (64–79)
PPD+/sst2A
+ neurons per mouse. The vast majority
(95.8%, range 92.2–100%) of galanin-immunoreactive
cells were also PPD+, and galanin was present in 85%
(range 81–92%) of the PPD+/sst2A
+ cells (Fig. 6).PdynCre;Ai9 mouse
In the sections from the PdynCre;Ai9 mice, tdTom-positive
neurons were seen throughout the dorsal horn, but were
present at a relatively high density in laminae I–II
(Fig. 7a). Between 63 and 112 tdTom+ neurons were
identiﬁed in each of the four mice (two sections per
mouse), and these cells constituted 13.9% (range 11.5–
17.7%) of all neurons in laminae I–II, and 4.3% (2.6–
6.3%) of those in lamina III. Two sections each from two
mice were analyzed for expression of nNOS and Pax2.
We identiﬁed a total of 164 nNOS-expressing inhibitory
interneurons (i.e. cells that were both nNOS- and Pax2-
immunoreactive) in laminae I–III in these sections (81,
83 in each mouse) and found that 82% of these cells
(77%, 86%) were tdTom-positive (Fig. 7d–f). We also
identiﬁed 299 nNOS-expressing excitatory (Pax2-
negative) neurons (152, 147 in each mouse) and found
that only one of these cells (0.3%) contained tdTomato.This indicates that most inhibitory nNOS cells express
dynorphin at some stage during their development, but
that this is not the case for excitatory nNOS cells.
We analyzed two sections from each of the three mice
that received intraspinal injection of AAV.ﬂex.eGFP, and
found that 79% (range 71–84%) of the tdTom+ neurons
in laminae I–II in the region near the injection site
contained eGFP, indicating that they continued to
express dynorphin past the early postnatal period
(Fig. 7a–c). The lack of eGFP in the remaining 21% of
tdTom+ neurons could have resulted from either lack of
infection by the AAV, or because these cells no longer
expressed dynorphin. As expected, virtually all
(243/245, 99%) of the eGFP-containing cells were
tdTom+. The results of the neurochemical analysis of
eGFP-positive and eGFP-negative tdTom cells were
similar across the three mice, and data were therefore
pooled (Table 2). Among tdTom+ cells in laminae I–II,
72% were PPD-immunoreactive, whereas among eGFP-
containing cells the proportion rose to 85%. The lack of
detectable PPD-immunoreactivity in 15% of eGFP cells
may have resulted from the lower sensitivity of the TSA-
Cy5 kit, which had to be used in this case because the
TSA-tetramethylrhodamine product could not be
distinguished from tdTom ﬂuorescence. The great
majority (93%) of the PPD-immunoreactive tdTom+
cells contained eGFP (Fig. 8a–d), and the small number
that did not contain eGFP probably results from lack of
infection of these cells by the injected AAV.
Nonetheless, these results indicate that PPD can be
detected in the cell bodies of the great majority of cells
that continue to express dynorphin, as deﬁned by the
presence of eGFP. Interestingly, we found that a
smaller proportion of the nNOS-immunoreactive tdTom+
cells (40/69, 58%) contained eGFP compared to the
remaining (nNOS-negative) tdTom+ cells (203/240,
85%) (Fig. 8e–h). This diﬀerence was highly signiﬁcant
(Chi-squared test, p< 0.0001), indicating that nNOS+
tdTom cells were under-represented among those that
continue to express dynorphin. This suggests that
although most inhibitory nNOS cells in laminae I–III
initially express dynorphin, many of these cells cease to
do so during development.DISCUSSION
The main ﬁndings of this study are: (1) that NPY-
immunoreactivity is restricted to inhibitory interneurons
in laminae I–III, but is present in a far higher proportion
(33%) of these cells than we found in the rat; (2) that
PPD expression largely overlaps with that of galanin,
and shows 10% co-localization with NPY; (3) that as
in the rat, NPY, nNOS and parvalbumin inhibitory
interneuron populations show little or no overlap; and (4)
that although the distribution of inhibitory PPD cells in
laminae I–II appears uniform, the pattern is quite
diﬀerent for excitatory PPD cells, which are clustered in
the medial third of the dorsal horn at the L4 level,
corresponding to the region innervated from glabrous
skin.
Fig. 5. The distribution of inhibitory and excitatory neurons that express preprodynorphin (PPD) in mouse lumbar spinal cord. (A) The distribution of
PPD-immunoreactive cells identiﬁed in the L4 segments of four mice and plotted onto an outline of the dorsal horn. Pax2-negative (excitatory)
neurons are shown in red and Pax2-positive (inhibitory) neurons are shown in blue. The upper and lower dashed lines represent the borders of
lamina III. Note that although inhibitory PPD neurons are evenly distributed throughout the superﬁcial dorsal horn, the excitatory cells are clustered
in the medial one third. (B) A corresponding plot for the distribution of PPD-immunoreactive cells in the L2 segment of four mice shows that there are
very few excitatory (Pax2-negative) cells, and these are scattered throughout the superﬁcial laminae. (C–E) Confocal images from the middle part of
lamina II in the L4 segment scanned to reveal PPD (magenta), NeuN (yellow), Pax2 (green) and sst2A (blue). Four PPD-immunoreactive neurons
are indicated with arrows, and all of these are also immunoreactive for both Pax2 and sst2A, indicating that they are all inhibitory interneurons. (F–H)
Corresponding confocal images from the medial part of lamina II in L4, scanned in the same way. This ﬁeld includes two PPD cells with both Pax2
and sst2A (arrows), as well as three PPD cells that lack both Pax2 and sst2A (arrowheads) and are therefore excitatory interneurons. All confocal
images are projections of two optical sections at 1-lm z-spacing. Scale bar (applies to all confocal images) = 20 lm. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 6. Co-expression of preprodynorphin (PPD), galanin (gal) and sst2A in lamina II neurons. A scan through the superﬁcial dorsal horn from a
section that had been reacted with antibodies against NeuN (blue), PPD (red), galanin (green) and sst2A (gray). (A–D) Three NeuN-positive cells
that are immunoreactive for PPD, galanin and sst2A are indicated with arrows. (E) A merged image, showing NeuN, PPD and galanin. The images
are from a single optical section. Scale bar = 20 lm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
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Fig. 7. Expression of enhanced green ﬂuorescent protein (eGFP) and tdTomato (tdTom) in a PdynCre;Ai9 mouse that had received an intraspinal
injection of AAV.ﬂex.eGFP at P44. (A) tdTom-positive cells (magenta) are particularly numerous in laminae I–II, but are scattered throughout the
remainder of the dorsal horn. (B, C) eGFP (green) is expressed in many, but not all of the tdTom cells, and three cells that lack eGFP are indicated
with arrowheads. Note that virtually all of the eGFP cells also express tdTom. The dashed line indicates the lamina II–III border. (D–F) A single
optical section through a PdynCre;Ai9 mouse that had been reacted to reveal nNOS (green) and Pax2 (blue). Three nNOS-positive cells with Pax2-
immunoreactive nuclei are shown with arrows. These correspond to nNOS-expressing inhibitory interneurons, and all three are tdTom-positive. Two
other nNOS-positive cells that lack Pax2 are also visible (*) and these cells, which correspond to nNOS-expressing excitatory neurons, lack tdTom.
Note that the excitatory nNOS cells show much weaker immunoreactivity for nNOS. The images in A–C were obtained from 45 optical sections at
1-lm z-spacing. Scale bar = 100 lm (A–C), 20 lm (D–F). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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interneurons in laminae I–II
The results of this study, taken together with quantitative
data from our previous studies (Iwagaki et al., 2013;
Polgar et al., 2013a) allow us to estimate the sizes of
the various neurochemical populations that we have iden-tiﬁed among inhibitory interneurons in the superﬁcial dor-
sal horn of the mouse spinal cord.
As noted above, our ﬁndings suggest that
parvalbumin cells account for around 11% of inhibitory
interneurons in laminae I–II. This population shows
essentially no overlap with nNOS cells, and only 4% of
Table 2. PPD- and nNOS-immunoreactivity and eGFP expression among tdTom-positive cells in the PdynCre mice injected with AAV.ﬂex.eGFP
eGFP+ eGFP-
PPD+/nNOS+ PPD+/nNOS PPD-/nNOS+ PPD-/nNOS PPD+/nNOS+ PPD+/nNOS PPD-/nNOS+ PPD-/nNOS
26
(3–12)
180
(57–64)
14
(3–7)
23
(5–9)
4
(1–3)
12
(0–10)
25
(4–13)
25
(2–18)
Total 243 66
Fig. 8. Expression of enhanced green ﬂuorescent protein (eGFP) and tdTomato (tdTom) in neurons that contain preprodynorphin (PPD) or
neuronal nitric oxide synthase (nNOS) in a PdynCre;Ai9 mouse that had received an intraspinal injection of AAV.ﬂex.eGFP at P44. (A–D) Two cells
that express both tdTom (red) and eGFP (green) are immunoreactive for PPD (blue) and are indicated with arrows. (E–H) This ﬁeld shows two
tdTom-expressing cells that are immunoreactive for nNOS (blue). One of these (arrow) is positive for eGFP, while the other (arrowhead) is not. All
images are from single optical sections. Scale bar = 20 lm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
Fig. 9. Proportions of inhibitory interneurons in laminae I–II that
belong to diﬀerent neurochemical populations. The pie chart shows
the estimated proportions of all inhibitory interneurons in laminae I–II
that are accounted for by each neurochemical population. There is
considerable overlap between galanin/dynorphin (red) and nNOS
(blue) populations, shown in purple. Similarly there is limited overlap
between galanin/dynorphin cells and the NPY population (green) and
this is shown in brown. Note that there is also a small overlap of the
NPY population with both nNOS and parvalbumin cells, and this is not
shown on the pie chart. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this
article.)
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0.5% of all inhibitory neurons). Although we did not
directly compare galanin and parvalbumin it is unlikely
that there is a signiﬁcant co-expression, because
parvalbumin cells are highly concentrated in lamina IIi–V
(Hughes et al., 2012; Abraira et al., 2017), while the gala-
nin cells are largely restricted to laminae I–IIo (Tiong
et al., 2011; Iwagaki et al., 2013).
We have previously provided quantitative data
concerning inhibitory interneurons that express galanin
and/or nNOS in laminae I–II of the mouse (Iwagaki
et al., 2013). We reported that all galanin cells were sst2A-
positive, and that these accounted for 44% of the sst2A
cells. Since sst2A is expressed by 54% of inhibitory
interneurons in laminae I–II (Polgar et al., 2013a), this
means that galanin can be detected in 24% of inhibitory
neurons in this region. Similarly, nNOS was present in
30% of the sst2A cells, and since 95% of inhibitory nNOS
cells are sst2A
+ , nNOS cells would correspond to 17% of
the inhibitory neurons. However, there is a moderate
degree of overlap between galanin and nNOS in the
mouse. Galanin and/or nNOS neurons make up 61% of
the sst2A cells, and if we allow for the small number of inhi-
bitory nNOS neurons that lack sst2A, then we estimate
that the combined populations constitute 34% of all inhibi-
tory cells in laminae I–II.
From the present results, we conclude that NPY can
be detected in 33% of the inhibitory cells in the
superﬁcial dorsal horn, and this is considerably higherthan our estimate (18%) for the corresponding
population in the rat (Polga´r et al., 2011). Although there
may be a signiﬁcant species diﬀerence in the proportion
of inhibitory interneurons that express NPY, a more likely
explanation is that in the mouse, cells that synthesize
NPY have higher levels of the peptide in their perikaryal
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tion threshold for immunocytochemistry. We found that
13% of NPY cells were PPD+, and three-quarters of
these were sst2A-immunoreactive. We had previously
reported that 24% of NPY cells in the mouse were sst2A-
immunoreactive (Iwagaki et al., 2013), and the present
results show that around two-ﬁfths of these cells also
express dynorphin. We did not directly investigate co-
localization of NPY and galanin, because the two antibod-
ies that we used to detect these peptides were both raised
in rabbit. However, our ﬁndings with PPD and NPY pro-
vide an indication of the likely extent of co-expression.
Since galanin is found in most dynorphin-expressing inhi-
bitory neurons, but is restricted to those with sst2A, 10%
of the NPY cells are likely to co-express galanin, and this
would correspond to 3.3% of all inhibitory neurons. Simi-
larly, nNOS was detected in 4.4% of NPY cells, which
would equate to 1.5% of the inhibitory cells.
Based on these numbers, we estimate that cells that
contain one or more of these four neurochemical
markers make up 75% of the inhibitory (GABAergic)
interneurons in laminae I–II of the mouse dorsal horn.
Interestingly, Smith et al. (2015) recently identiﬁed a novel
population of calretinin-expressing inhibitory cells, which
constituted 25% of the Pax2-positive neurons in this
region, and which showed very little overlap with the
NPY, nNOS or galanin populations that we describe here.
In addition, we have found that they do not overlap with
the parvalbumin-immunoreactive cells (AJT and M Mus-
tapa, unpublished observations). This means that most,
if not all, inhibitory interneurons in laminae I–II are likely
to belong to one of these ﬁve neurochemical populations
(Fig. 9).
The opioid peptide enkephalin is expressed by many
neurons in laminae I–III (Todd, 2017). These include both
excitatory and inhibitory interneurons (Huang et al., 2010;
Francois et al., 2017), and some of the enkephalin cells
also express nNOS or parvalbumin (Huang et al., 2010).
However, both of these proteins are also found in excita-
tory cells, and it is not yet known whether the inhibitory
enkephalinergic neurons correspond to one or more of
the classes that we deﬁne here.
Functions of the diﬀerent neurochemical populations
Among these populations, the function is probably best
understood for the parvalbumin cells, which are found in
lamina IIi and the deep dorsal horn (Antal et al., 1990;
Laing et al., 1994; Hughes et al., 2012; Abraira et al.,
2017). Hughes et al. (2012) demonstrated that these cells
received monosynaptic input from low-threshold myeli-
nated (A-LTMR) aﬀerents, and that their axons frequently
formed axoaxonic synapses onto A-LTMR aﬀerents,
which suggests that they play an important role in inhibit-
ing tactile input. Direct evidence for this was subsequently
provided by Petitjean et al. (2015), who showed that ablat-
ing parvalbumin neurons led to mechanical hypersensitiv-
ity, while activating them increased mechanical pain
thresholds and alleviated tactile allodynia in a neuropathic
pain model.
We have previously demonstrated that the
galanin/dynorphin and nNOS inhibitory interneuronpopulations both depend on the transcription factor
Bhlhb5 during development, and we therefore refer to
these as B5-I neurons (Chiang et al., 2016). Since Bhlh-
b5/ mice show chronic itch, we concluded that the B5-
I neurons include cells that suppress itch in response to
counterstimuli (Kardon et al., 2014). Because dynorphin
acts on the j opioid receptor (KOR), and intrathecally
administered KOR agonists suppressed itch, we also pro-
posed that loss of KOR signaling (secondary to depletion
of dynorphin) was likely to contribute to the exaggerated
itch seen in Bhlhb5/ mice (Kardon et al., 2014). There
is evidence that neuropeptides can initially be expressed
in a relatively large number of superﬁcial dorsal horn neu-
rons during development, with expression being switched
oﬀ in some of these cells (Duan et al., 2014; Gutierrez-
Mecinas et al., 2017). It has also been shown that expres-
sion of nNOS in this region occurs relatively late during
development, with nNOS-expressing cells reaching their
deﬁnitive number in the 3rd week after birth in the rat
(Liuzzi et al., 1993). We had therefore speculated that
some B5-I cells might switch from neuropeptide to nNOS
expression during early development (Iwagaki et al.,
2013). Our ﬁndings in the PdynCre mouse conﬁrm this pre-
diction, since nNOS-expressing inhibitory interneurons
were over-represented among the tdTom+/eGFP neu-
rons (i.e. ‘‘transient dynorphin” cells), following injection
of AAV.ﬂex.eGFP. Duan et al. (2014) used the same
PdynCre line with an intersectional strategy that allowed
them to ablate only the inhibitory dynorphin neurons.
However, the present results show that they would prob-
ably have aﬀected more than just those inhibitory
interneurons that continue to express dynorphin in the
adult. This ablation resulted in a dramatic increase in
mechanical pain, indicating a major role for the B5-I neu-
rons in suppressing transmission of noxious mechanical
input to dorsal horn projection neurons.
Although the main purpose of this study was to
investigate inhibitory interneurons, we also made a
surprising observation concerning the distribution of
Pax2-negative PPD neurons. These cells, most of which
are presumably excitatory interneurons (Sardella et al.,
2011a), were far more numerous in the medial one-third
of the L4 segment than in the remaining parts of this seg-
ment, or in L2, and this presumably reﬂects an associa-
tion with sensory inputs from glabrous skin.
Interestingly, although we had reported an almost com-
plete loss of PPD-immunoreactive cells in the Bhlhb5/
mouse (Kardon et al., 2014), Duan et al. (2014) subse-
quently found a much smaller reduction in the number
of PPD mRNA cells (50%) in the same knockout. Our
analysis of dynorphin neurons was made in the L3 seg-
ment, which receives little input from glabrous skin
(Takahashi et al., 2003), and would therefore likely have
contained predominantly inhibitory PPD neurons.
Although Duan et al. do not indicate which segment(s)
they analyzed, the PPD mRNA cells that they illustrate
in the Bhlhb5/ mouse are highly concentrated in the
medial part of the dorsal horn (their Fig. S7L). If this image
was taken from the L4 or L5 segment, these could be the
excitatory PPD neurons. These cells are likely to be
retained in the Bhlhb5/ mouse, as there is no evidence
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2010), and we have observed numerous PPD-
immunoreactive neurons that lack Pax2 in the medial part
of the L5 segment in these mice (MGM, KAB, AJT unpub-
lished observations).
Relatively little is known about the functions of NPY-
expressing interneurons. NPY itself can act on Y1 and
Y2 receptors, which are widely expressed on dorsal
horn neurons and central terminals of primary aﬀerents,
and the majority of studies have reported that NPY has
an antinociceptive eﬀect (Brumovsky et al., 2007; Smith
et al., 2007). However, although knockdown of NPY pro-
longed neuropathic or inﬂammatory pain, it had little eﬀect
on acute nociceptive thresholds, suggesting that under
physiological conditions, NPY is only antinociceptive in
chronic pain states (Solway et al., 2011). Since the
NPY-expressing cells account for nearly a third of
GABAergic neurons in laminae I–II and around a quarter
of those in lamina III, they are likely to make an important
contribution to GABAergic inhibitory mechanisms in the
dorsal horn. Many of these cells respond to noxious stim-
uli (Polgar et al., 2013b; Iwagaki et al., 2016), which sug-
gests that they are involved in antinociception. A recent
study by Bourane et al. (2015) used a bacterial artiﬁcial
chromosome transgenic mouse, in which Cre is
expressed under control of the NPY promoter to investi-
gate the function of NPY neurons in the dorsal horn. They
reported that ablation of Cre-expressing cells evoked a
form of mechanical itch in hairy skin, but caused no alter-
ations in responses to painful stimuli. This is surprising,
given the widespread distribution of NPY-expressing cells
and axons, which are present throughout the mediolateral
extent of the dorsal horn, including regions that receive
input from glabrous skin. However, only 35% of the cells
that were targeted by Bourane et al. were positive for NPY
mRNA in adult mice, suggesting that many of them were
transient NPY expressers. It is therefore not clear to what
extent the population that they ablated corresponds to the
NPY-immunoreactive inhibitory interneurons that we
describe. Further studies will be needed to assess the
roles of NPY-expressing inhibitory interneurons.CONCLUSION
The present results show that expression of
galanin/dynorphin, NPY, nNOS and parvalbumin deﬁnes
four largely non-overlapping populations that account for
75% of the inhibitory interneurons in laminae I–II of
the mouse dorsal horn. When taken together with a
recently identiﬁed population of calretinin-expressing
cells, our ﬁndings suggest that virtually all of the
inhibitory neurons in the superﬁcial dorsal horn can be
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